Keywords
Last Name
Institution

Mark G. Lebwohl

TitlePROFESSOR & CHAIR
InstitutionMount Sinai
DepartmentDermatology
Address5 East 98th Street, 5th Floor
New York NY 10029
Phone212-241-9728
Fax212-876-5661

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Kircik LH, Lebwohl MG, Del Rosso JQ, Bagel J, Stein Gold L, Weiss JS. Clinical study results of desoximetasone spray, 0.25% in moderate to severe plaque psoriasis. J Drugs Dermatol. 2013 Dec 1; 12(12):1404-10.
      View in: PubMed
    2. Motaparthi K, Stanisic V, Van Voorhees AS, Lebwohl MG, Hsu S. From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis. J Am Acad Dermatol. 2014 Jan; 70(1):178-86.
      View in: PubMed
    3. Linkner RV, Sohn A, Goldenberg KA, Lebwohl M. Infrared camera evaluation of the cooling effect of triamcinolone acetonide aerosol. J Clin Aesthet Dermatol. 2013 Nov; 6(11):28-31.
      View in: PubMed
    4. Hugh J, Van Voorhees AS, Nijhawan RI, Bagel J, Lebwohl M, Blauvelt A, Hsu S, Weinberg JM. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J Am Acad Dermatol. 2014 Jan; 70(1):168-77.
      View in: PubMed
    5. Ryan C, Korman NJ, Gelfand JM, Lim HW, Elmets CA, Feldman SR, Gottlieb AB, Koo JY, Lebwohl M, Leonardi CL, Van Voorhees AS, Bhushan R, Menter A. Research gaps in psoriasis: Opportunities for future studies. J Am Acad Dermatol. 2014 Jan; 70(1):146-67.
      View in: PubMed
    6. Heinecke GM, Luber AJ, Levitt JO, Lebwohl MG. Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center. J Drugs Dermatol. 2013 Oct; 12(10):1098-102.
      View in: PubMed
    7. Armstrong AW, Robertson AD, Wu J, Schupp C, Lebwohl MG. Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011. JAMA Dermatol. 2013 Oct; 149(10):1180-5.
      View in: PubMed
    8. Strober BE, Nyirady J, Mallya UG, Guettner A, Papavassilis C, Gottlieb AB, Elewski BE, Turner-Bowker DM, Shields AL, Gwaltney CJ, Lebwohl M. Item-level psychometric properties for a new patient-reported psoriasis symptom diary. Value Health. 2013 Sep-Oct; 16(6):1014-22.
      View in: PubMed
    9. Lebwohl MG, Del Rosso JQ, Abramovits W, Berman B, Cohen DE, Guttman E, Mancini AJ, Schachner LA. Pathways to managing atopic dermatitis: consensus from the experts. J Clin Aesthet Dermatol. 2013 Jul; 6(7 Suppl):S2-S18.
      View in: PubMed
    10. Lebwohl M, Shumack S, Stein Gold L, Melgaard A, Larsson T, Tyring SK. Long-term follow-up study of ingenol mebutate gel for the treatment of actinic keratoses. JAMA Dermatol. 2013 Jun; 149(6):666-70.
      View in: PubMed
    11. Lebwohl MG, Kircik L, Callis Duffin K, Pariser D, Hooper M, Wenkert D, Thompson EH, Yang J, Kricorian G, Koo J. A randomized study to evaluate the efficacy and safety of adding topical therapy to etanercept in patients with moderate to severe plaque psoriasis. J Am Acad Dermatol. 2013 Sep; 69(3):385-92.
      View in: PubMed
    12. Haddican M, Gagliotti M, Lebwohl M. Reduced burning and stinging associated with topical application of lactic acid 10% with strontium versus ammonium lactate 12%. Cutis. 2013 May; 91(5):260-2.
      View in: PubMed
    13. Papp KA, Griffiths CE, Gordon K, Lebwohl M, Szapary PO, Wasfi Y, Chan D, Hsu MC, Ho V, Ghislain PD, Strober B, Reich K. Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol. 2013 Apr; 168(4):844-54.
      View in: PubMed
    14. de Vries AC, Bogaards NA, Hooft L, Velema M, Pasch M, Lebwohl M, Spuls PI. Interventions for nail psoriasis. Cochrane Database Syst Rev. 2013; 1:CD007633.
      View in: PubMed
    15. Grimes PE, Hamzavi I, Lebwohl M, Ortonne JP, Lim HW. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo. JAMA Dermatol. 2013 Jan; 149(1):68-73.
      View in: PubMed
    16. Menter A, Gold LS, Bukhalo M, Grekin S, Kempers S, Boyce BM, Ganslandt C, Villumsen J, Lebwohl M. Calcipotriene plus betamethasone dipropionate topical suspension for the treatment of mild to moderate psoriasis vulgaris on the body: a randomized, double-blind, vehicle-controlled trial. J Drugs Dermatol. 2013 Jan; 12(1):92-8.
      View in: PubMed
    17. Rosen T, Lebwohl MG. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol. 2013 Jan; 68(1 Suppl 1):S2-9.
      View in: PubMed
    18. Lebwohl M. Interleukin 12/23 agents and major adverse cardiovascular events. Arch Dermatol. 2012 Nov; 148(11):1329.
      View in: PubMed
    19. Lebwohl M. JDD: celebrating 10 years of publishing excellence. J Drugs Dermatol. 2012 Oct; 11(10):1150.
      View in: PubMed
    20. Kragballe K, Menter A, Lebwohl M, Tebbey PW, van de Kerkhof PC. Long-term management of scalp psoriasis: perspectives from the International Psoriasis Council. J Dermatolog Treat. 2013 Jun; 24(3):188-92.
      View in: PubMed
    21. Robinson A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF, Kalb RE. Treatment of pustular psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012 Aug; 67(2):279-88.
      View in: PubMed
    22. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B. Ingenol mebutate gel for actinic keratosis. N Engl J Med. 2012 Mar 15; 366(11):1010-9.
      View in: PubMed
    23. Reich K, Papp KA, Griffiths CE, Szapary PO, Yeilding N, Wasfi Y, Ott E, Hsu MC, Lebwohl M, Gordon KB. An update on the long-term safety experience of ustekinumab: results from the psoriasis clinical development program with up to four years of follow-up. J Drugs Dermatol. 2012 Mar; 11(3):300-12.
      View in: PubMed
    24. Lebwohl M, Preston N, Gottschalk RW. Impact of Baseline Disease Severity Over 26 and 52 Weeks of Treatment with Calcitriol Ointment 3µg/g in Patients with Mild-to-moderate Plaque Psoriasis. J Clin Aesthet Dermatol. 2012 Feb; 5(2):28-33.
      View in: PubMed
    25. Hsu S, Papp KA, Lebwohl MG, Bagel J, Blauvelt A, Duffin KC, Crowley J, Eichenfield LF, Feldman SR, Fiorentino DF, Gelfand JM, Gottlieb AB, Jacobsen C, Kalb RE, Kavanaugh A, Korman NJ, Krueger GG, Michelon MA, Morison W, Ritchlin CT, Stein Gold L, Stone SP, Strober BE, Van Voorhees AS, Weiss SC, Wanat K, Bebo BF. Consensus guidelines for the management of plaque psoriasis. Arch Dermatol. 2012 Jan; 148(1):95-102.
      View in: PubMed
    26. Stevenson ML, Lebwohl M. Iatrogenic effects of biologics for psoriasis. Clin Dermatol. 2011 Nov-Dec; 29(6):614-21.
      View in: PubMed
    27. Bae YS, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo B, Kimball AB. Review of treatment options for psoriasis in pregnant or lactating women: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2012 Sep; 67(3):459-77.
      View in: PubMed
    28. Lebwohl M, Leonardi C, Griffiths CE, Prinz JC, Szapary PO, Yeilding N, Guzzo C, Li S, Hsu MC, Strober B. Long-term safety experience of ustekinumab in patients with moderate-to-severe psoriasis (Part I of II): results from analyses of general safety parameters from pooled Phase 2 and 3 clinical trials. J Am Acad Dermatol. 2012 May; 66(5):731-41.
      View in: PubMed
    29. Patel RV, Lebwohl M. In the clinic. Psoriasis. Ann Intern Med. 2011 Aug 2; 155(3):ITC2-1-ICT2-15; quiz ITC2-16.
      View in: PubMed
    30. Emer JJ, Frankel A, Sohn A, Lebwohl M. A bilateral comparison study of pimecrolimus cream 1% and a topical medical device cream in the treatment of patients with atopic dermatitis. J Drugs Dermatol. 2011 Jul; 10(7):735-43.
      View in: PubMed
    31. Fernandes NF, Mercer SE, Kleinerman R, Lebwohl MG, Phelps RG. Amyloidosis cutis dyschromica associated with atypical Parkinsonism, spasticity and motor weakness in a Pakistani female. J Cutan Pathol. 2011 Oct; 38(10):827-31.
      View in: PubMed
    32. Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: consensus conference. J Am Acad Dermatol. 2011 Jun; 64(6):1179.
      View in: PubMed
    33. Frankel A, Sohn A, Patel RV, Lebwohl M. Bilateral comparison study of pimecrolimus cream 1% and a ceramide-hyaluronic acid emollient foam in the treatment of patients with atopic dermatitis. J Drugs Dermatol. 2011 Jun; 10(6):666-72.
      View in: PubMed
    34. Lebwohl M. ACP journal club. Regular sunscreen use reduces invasive but not overall melanoma in white adults. Ann Intern Med. 2011 May 17; 154(10):JC5-12.
      View in: PubMed
    35. van de Kerkhof PC, Kragballe K, Segaert S, Lebwohl M. Factors impacting the combination of topical corticosteroid therapies for psoriasis: perspectives from the International Psoriasis Council. J Eur Acad Dermatol Venereol. 2011 Oct; 25(10):1130-9.
      View in: PubMed
    36. Yoo JY, Blum RR, Singer GK, Stern DK, Emanuel PO, Fuchs W, Phelps RG, Terry SF, Lebwohl MG. A randomized controlled trial of oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol. 2011 Aug; 65(2):341-8.
      View in: PubMed
    37. Grozdev IS, Van Voorhees AS, Gottlieb AB, Hsu S, Lebwohl MG, Bebo BF, Korman NJ. Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2011 Sep; 65(3):537-45.
      View in: PubMed
    38. Frankel A, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl M, Bebo BF, Gottlieb A. In response to "Treatment of psoriasis with cyclosporine in patients with hepatitis C infection: risk or opportunity?". J Am Acad Dermatol. 2011 Apr; 64(4):788-90.
      View in: PubMed
    39. Reich K, Langley RG, Lebwohl M, Szapary P, Guzzo C, Yeilding N, Li S, Hsu MC, Griffiths CE. Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies. Br J Dermatol. 2011 Apr; 164(4):862-72.
      View in: PubMed
    40. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol. 2011 Jul; 65(1):137-74.
      View in: PubMed
    41. Hadi A, Lebwohl M. Clinical features of pyoderma gangrenosum and current diagnostic trends. J Am Acad Dermatol. 2011 May; 64(5):950-4.
      View in: PubMed
    42. Emer JJ, Frankel A, Sohn A, Lebwohl M. A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of Ammonium Lactate Lotion 12% and Halobetasol Propionate Ointment 0.05% in the Treatment and Maintenance of Psoriasis. J Clin Aesthet Dermatol. 2011 Feb; 4(2):28-39.
      View in: PubMed
    43. Lolis MS, Krishtul A, Vidal C, Shim-Chang H, Phelps R, Lebwohl M. Necrolytic migratory erythema associated with a metastatic neuroendocrine tumor. Cutis. 2011 Feb; 87(2):78-80.
      View in: PubMed
    44. Barker J, Horn EJ, Lebwohl M, Warren RB, Nast A, Rosenberg W, Smith C. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic. J Eur Acad Dermatol Venereol. 2011 Jul; 25(7):758-64.
      View in: PubMed
    45. Stern DK, Creasey AA, Quijije J, Lebwohl MG. UV-A and UV-B penetration of normal human cadaveric fingernail plate. Arch Dermatol. 2011 Apr; 147(4):439-41.
      View in: PubMed
    46. Levine D, Even-Chen Z, Lipets I, Pritulo OA, Svyatenko TV, Andrashko Y, Lebwohl M, Gottlieb A. Pilot, multicenter, double-blind, randomized placebo-controlled bilateral comparative study of a combination of calcipotriene and nicotinamide for the treatment of psoriasis. J Am Acad Dermatol. 2010 Nov; 63(5):775-81.
      View in: PubMed
    47. Lebwohl MG, Rosen T, Stockfleth E. The role of human papillomavirus in common skin conditions: current viewpoints and therapeutic options. Cutis. 2010 Nov; 86(5):suppl 1-11; quiz suppl 12.
      View in: PubMed
    48. Hadi SM, Al-Quran H, de Sá Earp AP, Hadi AS, Lebwohl M. The use of the 308-nm excimer laser for the treatment of psoriasis. Photomed Laser Surg. 2010 Oct; 28(5):693-5.
      View in: PubMed
    49. Lebwohl M, Yeilding N, Szapary P, Wang Y, Li S, Zhu Y, Reich K, Langley RG, Papp KA. Impact of weight on the efficacy and safety of ustekinumab in patients with moderate to severe psoriasis: rationale for dosing recommendations. J Am Acad Dermatol. 2010 Oct; 63(4):571-9.
      View in: PubMed
    50. Jorizzo JL, Markowitz O, Lebwohl MG, Bourcier M, Kulp J, Meng TC, Levy S. A randomized, double-blinded, placebo-controlled, multicenter, efficacy and safety study of 3.75% imiquimod cream following cryosurgery for the treatment of actinic keratoses. J Drugs Dermatol. 2010 Sep; 9(9):1101-8.
      View in: PubMed
    51. Zeichner JA, Lebwohl MG, Menter A, Bagel J, Del Rosso JQ, Elewski BE, Feldman SR, Kircik LH, Koo J, Gold LS, Tanghetti E. Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis. 2010 Sep; 86(3 Suppl):5-31; quiz 32.
      View in: PubMed
    52. Bremmer S, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo BF, Blauvelt A. Obesity and psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010 Dec; 63(6):1058-69.
      View in: PubMed
    53. Lebwohl M. Tumour necrosis factor-a blockers in the treatment of psoriasis. Br J Dermatol. 2010 Jun; 162(6):1169-71.
      View in: PubMed
    54. Kling MC, Larian AA, Scordi-Bello I, Emer J, Lebwohl MG. Fatal influenza A(H1N1) respiratory tract infection in a patient having psoriasis treated with infliximab. Arch Dermatol. 2010 Jun; 146(6):651-4.
      View in: PubMed
    55. Koutruba N, Emer J, Lebwohl M. Review of ustekinumab, an interleukin-12 and interleukin-23 inhibitor used for the treatment of plaque psoriasis. Ther Clin Risk Manag. 2010; 6:123-41.
      View in: PubMed
    56. Chaarani J, Lebwohl M. Alefacept: where it stands today. Expert Opin Drug Metab Toxicol. 2010 Mar; 6(3):355-61.
      View in: PubMed
    57. Alsufyani MA, Golant AK, Lebwohl M. Psoriasis and the metabolic syndrome. Dermatol Ther. 2010 Mar-Apr; 23(2):137-43.
      View in: PubMed
    58. Uliasz A, Lebwohl M. Evaluation of sensory irritation caused by topical medications using a novel technique. Int J Dermatol. 2010 Mar; 49(3):269-71.
      View in: PubMed
    59. Rosmarin DM, Lebwohl M, Elewski BE, Gottlieb AB. Cyclosporine and psoriasis: 2008 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2010 May; 62(5):838-53.
      View in: PubMed
    60. Lebwohl M, Papp K, Han C, Schenkel B, Yeilding N, Wang Y, Krueger GG. Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial. Br J Dermatol. 2010 Jan; 162(1):137-46.
      View in: PubMed
    61. Frankel AJ, Van Voorhees AS, Hsu S, Korman NJ, Lebwohl MG, Bebo BF, Gottlieb AB. Treatment of psoriasis in patients with hepatitis C: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 Dec; 61(6):1044-55.
      View in: PubMed
    62. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol. 2010 Jan; 62(1):114-35.
      View in: PubMed
    63. Rosenbach M, Hsu S, Korman NJ, Lebwohl MG, Young M, Bebo BF, Van Voorhees AS. Treatment of erythrodermic psoriasis: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010 Apr; 62(4):655-62.
      View in: PubMed
    64. Menon K, Van Voorhees AS, Bebo BF, Gladman DD, Hsu S, Kalb RE, Lebwohl MG, Strober BE. Psoriasis in patients with HIV infection: from the medical board of the National Psoriasis Foundation. J Am Acad Dermatol. 2010 Feb; 62(2):291-9.
      View in: PubMed
    65. Horn EJ, Domm S, Katz HI, Lebwohl M, Mrowietz U, Kragballe K. Topical corticosteroids in psoriasis: strategies for improving safety. J Eur Acad Dermatol Venereol. 2010 Feb; 24(2):119-24.
      View in: PubMed
    66. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol. 2009 Sep; 61(3):451-85.
      View in: PubMed
    67. Kalb RE, Strober B, Weinstein G, Lebwohl M. Methotrexate and psoriasis: 2009 National Psoriasis Foundation Consensus Conference. J Am Acad Dermatol. 2009 May; 60(5):824-37.
      View in: PubMed
    68. Chan CS, Van Voorhees AS, Lebwohl MG, Korman NJ, Young M, Bebo BF, Kalb RE, Hsu S. Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 Jun; 60(6):962-71.
      View in: PubMed
    69. Patel RV, Clark LN, Lebwohl M, Weinberg JM. Treatments for psoriasis and the risk of malignancy. J Am Acad Dermatol. 2009 Jun; 60(6):1001-17.
      View in: PubMed
    70. Lebwohl M, Ortonne JP, Andres P, Briantais P. Calcitriol ointment 3 microg/g is safe and effective over 52 weeks for the treatment of mild to moderate plaque psoriasis. Cutis. 2009 Apr; 83(4):205-12.
      View in: PubMed
    71. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb A, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol. 2009 Apr; 60(4):643-59.
      View in: PubMed
    72. Rozenblit M, Lebwohl M. New biologics for psoriasis and psoriatic arthritis. Dermatol Ther. 2009 Jan-Feb; 22(1):56-60.
      View in: PubMed
    73. Kalb RE, Bagel J, Korman NJ, Lebwohl MG, Young M, Horn EJ, Van Voorhees AS. Treatment of intertriginous psoriasis: from the Medical Board of the National Psoriasis Foundation. J Am Acad Dermatol. 2009 Jan; 60(1):120-4.
      View in: PubMed
    74. Zeichner JA, Stern DW, Uliasz A, Itenberg S, Lebwohl M. Placebo-controlled, double-blind, randomized pilot study of imiquimod 5% cream applied once per week for 6 months for the treatment of actinic keratoses. J Am Acad Dermatol. 2009 Jan; 60(1):59-62.
      View in: PubMed
    75. Halverstam CP, Lebwohl M. Nonstandard and off-label therapies for psoriasis. Clin Dermatol. 2008 Sep-Oct; 26(5):546-53.
      View in: PubMed
    76. Lebwohl M. What is Known About the Association of Antinuclear Antibodies Development During Treatment with TNF Blockers? J Clin Aesthet Dermatol. 2008 Sep; 1(3):36-7.
      View in: PubMed
    77. Kaufman ED, Lebwohl MG, Krueger GG, Zimmerman G, Horn EJ, Feldman SR. What the National Psoriasis Foundation means to dermatologists and our patients. Cutis. 2008 Sep; 82(3):181-3.
      View in: PubMed
    78. Uliasz A, Lebwohl M. A new standardized method of evaluating cutaneous irritation from topical medications. Cutis. 2008 Jul; 82(1):75-7.
      View in: PubMed
    79. Uliasz A, Zeichner J, Soung J, Wong V, Lebwohl M. A single-center, double-blind, randomized trial of the atrophogenic effects of fluocinonide cream 0.1% versus clobetasol propionate cream 0.05% in participants with corticosteroid-responsive dermatoses. Cutis. 2008 Jun; 81(6):517-9.
      View in: PubMed
    80. Papp KA, Langley RG, Lebwohl M, Krueger GG, Szapary P, Yeilding N, Guzzo C, Hsu MC, Wang Y, Li S, Dooley LT, Reich K. Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2). Lancet. 2008 May 17; 371(9625):1675-84.
      View in: PubMed
    81. Doherty SD, Van Voorhees A, Lebwohl MG, Korman NJ, Young MS, Hsu S. National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents. J Am Acad Dermatol. 2008 Aug; 59(2):209-17.
      View in: PubMed
    82. Uliasz A, Lebwohl M. Cutaneous manifestations of cardiovascular diseases. Clin Dermatol. 2008 May-Jun; 26(3):243-54.
      View in: PubMed
    83. Smith EC, Riddle C, Menter MA, Lebwohl M. Combining systemic retinoids with biologic agents for moderate to severe psoriasis. Int J Dermatol. 2008 May; 47(5):514-8.
      View in: PubMed
    84. Gottlieb A, Korman NJ, Gordon KB, Feldman SR, Lebwohl M, Koo JY, Van Voorhees AS, Elmets CA, Leonardi CL, Beutner KR, Bhushan R, Menter A. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol. 2008 May; 58(5):851-64.
      View in: PubMed
    85. Menter A, Gottlieb A, Feldman SR, Van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JY, Elmets CA, Korman NJ, Beutner KR, Bhushan R. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008 May; 58(5):826-50.
      View in: PubMed
    86. Patel V, Horn EJ, Lobosco SJ, Fox KM, Stevens SR, Lebwohl M. Psoriasis treatment patterns: results of a cross-sectional survey of dermatologists. J Am Acad Dermatol. 2008 Jun; 58(6):964-9.
      View in: PubMed
    87. Kimball AB, Gladman D, Gelfand JM, Gordon K, Horn EJ, Korman NJ, Korver G, Krueger GG, Strober BE, Lebwohl MG. National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening. J Am Acad Dermatol. 2008 Jun; 58(6):1031-42.
      View in: PubMed
    88. Wang Y, Zhou X, Weinstein E, Maryles B, Zhang Y, Moore J, Gao D, Atencio DP, Rosenstein BS, Lebwohl M, Chen HD, Xiao T, Wei H. p53 gene mutations in SKH-1 mouse tumors differentially induced by UVB and combined subcarcinogenic benzo[a]pyrene and UVA. Photochem Photobiol. 2008 Mar-Apr; 84(2):444-9.
      View in: PubMed
    89. Clark L, Lebwohl M. The effect of weight on the efficacy of biologic therapy in patients with psoriasis. J Am Acad Dermatol. 2008 Mar; 58(3):443-6.
      View in: PubMed
    90. Lebwohl M, Bagel J, Gelfand JM, Gladman D, Gordon KB, Hsu S, Kalb RE, Kimball AB, Korman NJ, Krueger GG, Mease P, Morison WL, Paller A, Pariser DM, Ritchlin C, Strober B, Van Voorhees A, Weinstein GD, Young M, Horn L. From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasis. J Am Acad Dermatol. 2008 Jan; 58(1):94-105.
      View in: PubMed
    91. Lebwohl M, Colón LE. The evolving role of topical treatments in adjunctive therapy for moderate to severe plaque psoriasis. Cutis. 2007 Nov; 80(5 Suppl):29-40.
      View in: PubMed
    92. Clark LN, Lebwohl M. Recent advances in medical dermatology. Int J Dermatol. 2007 Oct; 46(10):1005-10.
      View in: PubMed
    93. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol. 2007 Dec; 57(6):963-71.
      View in: PubMed
    94. Horn EJ, Fox KM, Patel V, Chiou CF, Dann F, Lebwohl M. Are patients with psoriasis undertreated? Results of National Psoriasis Foundation survey. J Am Acad Dermatol. 2007 Dec; 57(6):957-62.
      View in: PubMed
    95. Uliasz A, Lebwohl M. Patient education and regular surveillance results in earlier diagnosis of second primary melanoma. Int J Dermatol. 2007 Jun; 46(6):575-7.
      View in: PubMed
    96. Lebwohl M, Clark L, Levitt J. Therapy for head lice based on life cycle, resistance, and safety considerations. Pediatrics. 2007 May; 119(5):965-74.
      View in: PubMed
    97. Stern DK, Diamantis S, Smith E, Wei H, Gordon M, Muigai W, Moshier E, Lebwohl M, Spuls P. Water content and other aspects of brittle versus normal fingernails. J Am Acad Dermatol. 2007 Jul; 57(1):31-6.
      View in: PubMed
    98. Zeichner JA, Lebwohl M. Potential complications associated with the use of biologic agents for psoriasis. Dermatol Clin. 2007 Apr; 25(2):207-13, vii.
      View in: PubMed
    99. Lebwohl M, Menter A, Weiss J, Clark SD, Flores J, Powers J, Balin AK, Kempers S, Glinert RJ, Fleming T, Liu Y, Graeber M, Pariser DM. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies. J Drugs Dermatol. 2007 Apr; 6(4):428-35.
      View in: PubMed
    100. Krueger GG, Langley RG, Leonardi C, Yeilding N, Guzzo C, Wang Y, Dooley LT, Lebwohl M. A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis. N Engl J Med. 2007 Feb 8; 356(6):580-92.
      View in: PubMed
    101. Pariser DM, Bagel J, Gelfand JM, Korman NJ, Ritchlin CT, Strober BE, Van Voorhees AS, Young M, Rittenberg S, Lebwohl MG, Horn EJ. National Psoriasis Foundation clinical consensus on disease severity. Arch Dermatol. 2007 Feb; 143(2):239-42.
      View in: PubMed
    102. Lebwohl MG, Corvari L. Compatibility of topical therapies for psoriasis: challenges and innovations. Cutis. 2007 Jan; 79(1 Suppl 2):5-10.
      View in: PubMed
    103. Lebwohl MG. Advances in first-line topical therapies: the role of a 2-compound ointment for psoriasis vulgaris. Cutis. 2007 Jan; 79(1 Suppl 2):3-4.
      View in: PubMed
    104. Halverstam CP, Zeichner J, Lebwohl M. Lack of significant skeletal changes after long-term, low-dose retinoid therapy: case report and review of the literature. J Cutan Med Surg. 2006 Nov-Dec; 10(6):291-9.
      View in: PubMed
    105. Lebwohl M, Gower T. A safety assessment of topical calcineurin inhibitors in the treatment of atopic dermatitis. MedGenMed. 2006; 8(4):8.
      View in: PubMed
    106. Koo J, Blum RR, Lebwohl M. A randomized, multicenter study of calcipotriene ointment and clobetasol propionate foam in the sequential treatment of localized plaque-type psoriasis: short- and long-term outcomes. J Am Acad Dermatol. 2006 Oct; 55(4):637-41.
      View in: PubMed
    107. Smith E, Gordon M, Lebwohl M. Calcinosis cutis in a patient with eosinophilia-myalgia syndrome: case report. Cutis. 2006 Jun; 77(6):361-4.
      View in: PubMed
    108. Hadi S, Tinio P, Al-Ghaithi K, Al-Qari H, Al-Helalat M, Lebwohl M, Spencer J. Treatment of vitiligo using the 308-nm excimer laser. Photomed Laser Surg. 2006 Jun; 24(3):354-7.
      View in: PubMed
    109. Rigel AS, Lebwohl MG. Hat-wearing patterns in persons attending baseball games. J Am Acad Dermatol. 2006 May; 54(5):918-9.
      View in: PubMed
    110. Lebwohl M, Kathryn M. New roles for systemic retinoids. J Drugs Dermatol. 2006 May; 5(5):406-9.
      View in: PubMed
    111. Carey W, Glazer S, Gottlieb AB, Lebwohl M, Leonardi C, Menter A, Papp K, Rundle AC, Toth D. Relapse, rebound, and psoriasis adverse events: an advisory group report. J Am Acad Dermatol. 2006 Apr; 54(4 Suppl 1):S171-81.
      View in: PubMed
    112. Otley CC, Stasko T, Tope WD, Lebwohl M. Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg. 2006 Apr; 32(4):562-8.
      View in: PubMed
    113. Ringpfeil F, McGuigan K, Fuchsel L, Kozic H, Larralde M, Lebwohl M, Uitto J. Pseudoxanthoma elasticum is a recessive disease characterized by compound heterozygosity. J Invest Dermatol. 2006 Apr; 126(4):782-6.
      View in: PubMed
    114. Moore JO, Wang Y, Stebbins WG, Gao D, Zhou X, Phelps R, Lebwohl M, Wei H. Photoprotective effect of isoflavone genistein on ultraviolet B-induced pyrimidine dimer formation and PCNA expression in human reconstituted skin and its implications in dermatology and prevention of cutaneous carcinogenesis. Carcinogenesis. 2006 Aug; 27(8):1627-35.
      View in: PubMed
    115. Zeichner JA, Stern DW, Lebwohl M. Treatment of necrobiosis lipoidica with the tumor necrosis factor antagonist etanercept. J Am Acad Dermatol. 2006 Mar; 54(3 Suppl 2):S120-1.
      View in: PubMed
    116. Koo K, Brem H, Lebwohl M. Pyoderma gangrenosum versus chronic venous ulceration: comparison of diagnostic features. J Cutan Med Surg. 2006 Jan-Feb; 10(1):26-30.
      View in: PubMed
    117. Menter A, Cather JC, Baker D, Farber HF, Lebwohl M, Darif M. The efficacy of multiple courses of alefacept in patients with moderate to severe chronic plaque psoriasis. J Am Acad Dermatol. 2006 Jan; 54(1):61-3.
      View in: PubMed
    118. Pariser DM, Gordon KB, Papp KA, Leonardi CL, Kwon P, Compton PG, Rundle AC, Walicke PA, Lebwohl M. Clinical efficacy of efalizumab in patients with chronic plaque psoriasis: results from three randomized placebo-controlled Phase III trials: part I. J Cutan Med Surg. 2005 Dec; 9(6):303-12.
      View in: PubMed
    119. Lebwohl MG. Advances in psoriasis. Arch Dermatol. 2005 Dec; 141(12):1589-90.
      View in: PubMed
    120. Lebwohl M, Herrmann LG. Impaired skin barrier function in dermatologic disease and repair with moisturization. Cutis. 2005 Dec; 76(6 Suppl):7-12.
      View in: PubMed
    121. Wong VK, Lebwohl MG. Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist. Expert Opin Biol Ther. 2005 Nov; 5(11):1505-13.
      View in: PubMed
    122. Gao D, Luo Y, Guevara D, Wang Y, Rui M, Goldwyn B, Lu Y, Smith EC, Lebwohl M, Wei H. Benzo[a]pyrene and its metabolites combined with ultraviolet A synergistically induce 8-hydroxy-2'-deoxyguanosine via reactive oxygen species. Free Radic Biol Med. 2005 Nov 1; 39(9):1177-83.
      View in: PubMed
    123. Sherer DW, Singer G, Uribarri J, Phelps RG, Sapadin AN, Freund KB, Yanuzzi L, Fuchs W, Lebwohl M. Oral phosphate binders in the treatment of pseudoxanthoma elasticum. J Am Acad Dermatol. 2005 Oct; 53(4):610-5.
      View in: PubMed
    124. Miksch S, Lumsden A, Guenther UP, Foernzler D, Christen-Zäch S, Daugherty C, Ramesar RK, Lebwohl M, Hohl D, Neldner KH, Lindpaintner K, Richards RI, Struk B. Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6. Hum Mutat. 2005 Sep; 26(3):235-48.
      View in: PubMed
    125. Lebwohl M, Freeman A, Chapman MS, Feldman S, Hartle J, Henning A. Proven efficacy of tacrolimus for facial and intertriginous psoriasis. Arch Dermatol. 2005 Sep; 141(9):1154.
      View in: PubMed
    126. Wang Y, Gao D, Atencio DP, Perez E, Saladi R, Moore J, Guevara D, Rosenstein BS, Lebwohl M, Wei H. Combined subcarcinogenic benzo[a]pyrene and UVA synergistically caused high tumor incidence and mutations in H-ras gene, but not p53, in SKH-1 hairless mouse skin. Int J Cancer. 2005 Aug 20; 116(2):193-9.
      View in: PubMed
    127. Lebwohl M. A clinician's paradigm in the treatment of psoriasis. J Am Acad Dermatol. 2005 Jul; 53(1 Suppl 1):S59-69.
      View in: PubMed
    128. Gribetz CH, Blum R, Brady C, Cohen S, Lebwohl M. An extended 16-week course of alefacept in the treatment of chronic plaque psoriasis. J Am Acad Dermatol. 2005 Jul; 53(1):73-5.
      View in: PubMed
    129. Lebwohl M, Blum R, Berkowitz E, Kim D, Zitnik R, Osteen C, Wallis WJ. No evidence for increased risk of cutaneous squamous cell carcinoma in patients with rheumatoid arthritis receiving etanercept for up to 5 years. Arch Dermatol. 2005 Jul; 141(7):861-4.
      View in: PubMed
    130. Hochberg MC, Lebwohl MG, Plevy SE, Hobbs KF, Yocum DE. The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum. 2005 Jun; 34(6):819-36.
      View in: PubMed
    131. McKenna SP, Lebwohl M, Kahler KN. Development of the US PSORIQoL: a psoriasis-specific measure of quality of life. Int J Dermatol. 2005 Jun; 44(6):462-9.
      View in: PubMed
    132. Breneman D, Fleischer AB, Kaplan D, Lebwohl M, Miller B, Pariser D, Rist T, Swinyer L, Liu Y, Foley V. Clobetasol propionate 0.05% lotion in the treatment of moderate to severe atopic dermatitis: a randomized evaluation versus clobetasol propionate emollient cream. J Drugs Dermatol. 2005 May-Jun; 4(3):330-6.
      View in: PubMed
    133. Paller AS, Lebwohl M, Fleischer AB, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, Linowski GJ. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized, comparative studies. J Am Acad Dermatol. 2005 May; 52(5):810-22.
      View in: PubMed
    134. Soung J, Muigai W, Amin N, Stern DK, Lebwohl MG. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA). J Drugs Dermatol. 2005 May-Jun; 4(3):290-4.
      View in: PubMed
    135. Kazlow Stern D, Tripp JM, Ho VC, Lebwohl M. The use of systemic immune moderators in dermatology: an update. Dermatol Clin. 2005 Apr; 23(2):259-300.
      View in: PubMed
    136. Schwartz B, Lebwohl M. Complications of the smallpox vaccine. Int J Dermatol. 2005 Apr; 44(4):289-92.
      View in: PubMed
    137. Lebwohl M, Ting PT, Koo JY. Psoriasis treatment: traditional therapy. Ann Rheum Dis. 2005 Mar; 64 Suppl 2:ii83-6.
      View in: PubMed
    138. Lamba S, Krishtul A, Tan MH, Lebwohl MG. Acanthosis nigricans in a plaque of scleredema on the back of a diabetic patient: a case report. Int J Dermatol. 2005 Jan; 44(1):45-7.
      View in: PubMed
    139. Lebwohl MG. Use of etanercept in the dermatology setting. A review. Am J Clin Dermatol. 2005; 6(1):49-59.
      View in: PubMed
    140. Kang S, Bergfeld W, Gottlieb AB, Hickman J, Humeniuk J, Kempers S, Lebwohl M, Lowe N, McMichael A, Milbauer J, Phillips T, Powers J, Rodriguez D, Savin R, Shavin J, Sherer D, Silvis N, Weinstein R, Weiss J, Hammerberg C, Fisher GJ, Nighland M, Grossman R, Nyirady J. Long-term efficacy and safety of tretinoin emollient cream 0.05% in the treatment of photodamaged facial skin: a two-year, randomized, placebo-controlled trial. Am J Clin Dermatol. 2005; 6(4):245-53.
      View in: PubMed
    141. van de Kerkhof P, Griffiths CE, Christophers E, Lebwohl M, Krueger GG. Alefacept in the treatment of psoriasis in patients for whom conventional therapies are inadequate. Dermatology. 2005; 211(3):256-63.
      View in: PubMed
    142. Gribetz C, Ling M, Lebwohl M, Pariser D, Draelos Z, Gottlieb AB, Zaias N, Chen DM, Parneix-Spake A, Hultsch T, Menter A. Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study. J Am Acad Dermatol. 2004 Nov; 51(5):731-8.
      View in: PubMed
    143. Moore JO, Palep SR, Saladi RN, Gao D, Wang Y, Phelps RG, Lebwohl MG, Wei H. Effects of ultraviolet B exposure on the expression of proliferating cell nuclear antigen in murine skin. Photochem Photobiol. 2004 Nov-Dec; 80(3):587-95.
      View in: PubMed
    144. Gottlieb AB, Gordon KB, Lebwohl MG, Caro I, Walicke PA, Li N, Leonardi CL. Extended efalizumab therapy sustains efficacy without increasing toxicity in patients with moderate to severe chronic plaque psoriasis. J Drugs Dermatol. 2004 Nov-Dec; 3(6):614-24.
      View in: PubMed
    145. Lebwohl M, Freeman AK, Chapman MS, Feldman SR, Hartle JE, Henning A. Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol. 2004 Nov; 51(5):723-30.
      View in: PubMed
    146. Singh F, Lebwohl MG. Cutaneous T-cell lymphoma treatment using bexarotene and PUVA: a case series. J Am Acad Dermatol. 2004 Oct; 51(4):570-3.
      View in: PubMed
    147. Aaronson DS, Lebwohl M. Review of therapy of psoriasis: the prebiologic armamentarium. Dermatol Clin. 2004 Oct; 22(4):379-88, viii.
      View in: PubMed
    148. Prendergast MM, Abramovits W, Boguniewicz M, Lebwohl M, Tokar M, Tong KB. Look beyond financial conflicts of interest in evaluating industry-academia collaborations in burden-of-illness and outcomes research studies in dermatology. J Invest Dermatol. 2004 Sep; 123(3):452-4.
      View in: PubMed
    149. Saladi RN, Singh F, Wei H, Lebwohl MG, Phelps RG. Use of Ber-EP4 protein in recurrent metastatic basal cell carcinoma: a case report and review of the literature. Int J Dermatol. 2004 Aug; 43(8):600-3.
      View in: PubMed
    150. Hadi SM, Spencer JM, Lebwohl M. The use of the 308-nm excimer laser for the treatment of vitiligo. Dermatol Surg. 2004 Jul; 30(7):983-6.
      View in: PubMed
    151. Lebwohl M. Innovations in the treatment of psoriasis. J Am Acad Dermatol. 2004 Jul; 51(1 Suppl):S40-1.
      View in: PubMed
    152. Wong VK, Fuchs B, Lebwohl M. Overview on desonide 0.05%: a clinical safety profile. J Drugs Dermatol. 2004 Jul-Aug; 3(4):393-7.
      View in: PubMed
    153. Lebwohl M, Plott T. Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial. Int J Dermatol. 2004 Jul; 43 Suppl 1:17-20.
      View in: PubMed
    154. Lebwohl M, Dinehart S, Whiting D, Lee PK, Tawfik N, Jorizzo J, Lee JH, Fox TL. Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trials. J Am Acad Dermatol. 2004 May; 50(5):714-21.
      View in: PubMed
    155. Freeman AK, Serle J, VanVeldhuisen P, Lind L, Clarke J, Singer G, Lebwohl M. Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis. 2004 Apr; 73(4):267-71.
      View in: PubMed
    156. Koo J, Lee E, Lee CS, Lebwohl M. Psoriasis. J Am Acad Dermatol. 2004 Apr; 50(4):613-22.
      View in: PubMed
    157. Gottlieb AB, Kang S, Linden KG, Lebwohl M, Menter A, Abdulghani AA, Goldfarb M, Chieffo N, Totoritis MC. Evaluation of safety and clinical activity of multiple doses of the anti-CD80 monoclonal antibody, galiximab, in patients with moderate to severe plaque psoriasis. Clin Immunol. 2004 Apr; 111(1):28-37.
      View in: PubMed
    158. Lebwohl M, Menter A, Koo J, Feldman SR. Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol. 2004 Mar; 50(3):416-30.
      View in: PubMed
    159. Fuchs A, Fiedler J, Lebwohl M, Sapadin A, Rudikoff D, Lefkovits A, Schultz N, Khorenian S, Kakita L. Frequency of culture-proven dermatophyte infection in patients with suspected tinea pedis. Am J Med Sci. 2004 Feb; 327(2):77-8.
      View in: PubMed
    160. Stebbins WG, Lebwohl MG. Biologics in combination with nonbiologics: efficacy and safety. Dermatol Ther. 2004; 17(5):432-40.
      View in: PubMed
    161. Rigel EG, Lebwohl M, Rigel AC, Rigel DS. Daily UVB exposure levels in high-school students measured with digital dosimeters. J Am Acad Dermatol. 2003 Dec; 49(6):1112-4.
      View in: PubMed
    162. Lebwohl M, Tyring SK, Hamilton TK, Toth D, Glazer S, Tawfik NH, Walicke P, Dummer W, Wang X, Garovoy MR, Pariser D. A novel targeted T-cell modulator, efalizumab, for plaque psoriasis. N Engl J Med. 2003 Nov 20; 349(21):2004-13.
      View in: PubMed
    163. Lebwohl M. Actinic keratosis: epidemiology and progression to squamous cell carcinoma. Br J Dermatol. 2003 Nov; 149 Suppl 66:31-3.
      View in: PubMed
    164. Galadari H, Lebwohl M. Pseudoxanthoma elasticum: Temporary treatment of chin folds and lines with injectable collagen. J Am Acad Dermatol. 2003 Nov; 49(5 Suppl):S265-6.
      View in: PubMed
    165. Callen JP, Krueger GG, Lebwohl M, McBurney EI, Mease P, Menter A, Paller AS, Pariser DM, Weinblatt M, Zimmerman G. AAD consensus statement on psoriasis therapies. J Am Acad Dermatol. 2003 Nov; 49(5):897-9.
      View in: PubMed
    166. Wei H, Saladi R, Lu Y, Wang Y, Palep SR, Moore J, Phelps R, Shyong E, Lebwohl MG. Isoflavone genistein: photoprotection and clinical implications in dermatology. J Nutr. 2003 Nov; 133(11 Suppl 1):3811S-3819S.
      View in: PubMed
    167. Singh F, Gao D, Lebwohl MG, Wei H. Shikonin modulates cell proliferation by inhibiting epidermal growth factor receptor signaling in human epidermoid carcinoma cells. Cancer Lett. 2003 Oct 28; 200(2):115-21.
      View in: PubMed
    168. Lebwohl M, Quijije J, Gilliard J, Rollin T, Watts O. Topical calcitriol is degraded by ultraviolet light. J Invest Dermatol. 2003 Sep; 121(3):594-5.
      View in: PubMed
    169. Wong VK, Lebwohl M. The use of alefacept in the treatment of psoriasis. Skin Therapy Lett. 2003 Sep; 8(6):1-2, 7.
      View in: PubMed
    170. Lebwohl M. Combining the new biologic agents with our current psoriasis armamentarium. J Am Acad Dermatol. 2003 Aug; 49(2 Suppl):S118-24.
      View in: PubMed
    171. Kazlow DW, Federgrun D, Kurtin S, Lebwohl MG. Cutaneous ulceration caused by methotrexate. J Am Acad Dermatol. 2003 Aug; 49(2 Suppl Case Reports):S197-8.
      View in: PubMed
    172. Ruzicka T, Assmann T, Lebwohl M. Potential future dermatological indications for tacrolimus ointment. Eur J Dermatol. 2003 Jul-Aug; 13(4):331-42.
      View in: PubMed
    173. Lebwohl M, Christophers E, Langley R, Ortonne JP, Roberts J, Griffiths CE. An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis. Arch Dermatol. 2003 Jun; 139(6):719-27.
      View in: PubMed
    174. Wong VK, Della Croce C, Schonfeld S, Mastrangelo AM, Lebwohl M. Use and abuse of topical corticosteroids in infections of the skin and related structures. J Drugs Dermatol. 2003 Jun; 2(3):268-76.
      View in: PubMed
    175. Weinstein GD, Koo JY, Krueger GG, Lebwohl MG, Lowe NJ, Menter MA, Lew-Kaya DA, Sefton J, Gibson JR, Walker PS. Tazarotene cream in the treatment of psoriasis: Two multicenter, double-blind, randomized, vehicle-controlled studies of the safety and efficacy of tazarotene creams 0.05% and 0.1% applied once daily for 12 weeks. J Am Acad Dermatol. 2003 May; 48(5):760-7.
      View in: PubMed
    176. Rapaport MJ, Lebwohl M. Corticosteroid addiction and withdrawal in the atopic: the red burning skin syndrome. Clin Dermatol. 2003 May-Jun; 21(3):201-14.
      View in: PubMed
    177. Shyong EQ, Lu Y, Goldstein A, Lebwohl M, Wei H. Synergistic enhancement of H2O2 production in human epidermoid carcinoma cells by Benzo[a]pyrene and ultraviolet A radiation. Toxicol Appl Pharmacol. 2003 Apr 15; 188(2):104-9.
      View in: PubMed
    178. Lebwohl M. Psoriasis. Lancet. 2003 Apr 5; 361(9364):1197-204.
      View in: PubMed
    179. Lebwohl M, Lebwohl E, Bercovitch L. Prominent mental (chin) crease: a new sign of pseudoxanthoma elasticum. J Am Acad Dermatol. 2003 Apr; 48(4):620-2.
      View in: PubMed
    180. Freeman AK, Linowski GJ, Brady C, Lind L, Vanveldhuisen P, Singer G, Lebwohl M. Tacrolimus ointment for the treatment of psoriasis on the face and intertriginous areas. J Am Acad Dermatol. 2003 Apr; 48(4):564-8.
      View in: PubMed
    181. Saladi R, Austin L, Gao D, Lu Y, Phelps R, Lebwohl M, Wei H. The combination of benzo[a]pyrene and ultraviolet A causes an in vivo time-related accumulation of DNA damage in mouse skin. Photochem Photobiol. 2003 Apr; 77(4):413-9.
      View in: PubMed
    182. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Paller AS, Stevens SR, Whitaker-Worth DL, Tong KB. Cost-effectiveness analysis of tacrolimus ointment versus high-potency topical corticosteroids in adults with moderate to severe atopic dermatitis. J Am Acad Dermatol. 2003 Apr; 48(4):553-63.
      View in: PubMed
    183. Galadari H, Fuchs B, Lebwohl M. Newly available treatments for psoriatic arthritis and their impact on skin psoriasis. Int J Dermatol. 2003 Mar; 42(3):231-7.
      View in: PubMed
    184. Bercovitch L, Schepps B, Koelliker S, Magro C, Terry S, Lebwohl M. Mammographic findings in pseudoxanthoma elasticum. J Am Acad Dermatol. 2003 Mar; 48(3):359-66.
      View in: PubMed
    185. Ortonne JP, Lebwohl M, Em Griffiths C. Alefacept-induced decreases in circulating blood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis. Eur J Dermatol. 2003 Mar-Apr; 13(2):117-23.
      View in: PubMed
    186. Spuls PI, Rozenblit M, Lebwohl M. Retrospective study of the efficacy of narrowband UVB and acitretin. J Dermatolog Treat. 2003; 14 Suppl 2:17-20.
      View in: PubMed
    187. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Tong KB. Validation of expert opinion in identifying comorbidities associated with atopic dermatitis/eczema. Pharmacoeconomics. 2003; 21(12):875-83.
      View in: PubMed
    188. Rigel EG, Lebwohl MG, Rigel AC, Rigel DS. Ultraviolet radiation in alpine skiing: magnitude of exposure and importance of regular protection. Arch Dermatol. 2003 Jan; 139(1):60-2.
      View in: PubMed
    189. Fazekas Z, Gao D, Saladi RN, Lu Y, Lebwohl M, Wei H. Protective effects of lycopene against ultraviolet B-induced photodamage. Nutr Cancer. 2003; 47(2):181-7.
      View in: PubMed
    190. Lebwohl M, Tannis C, Carrasco D. Acitretin suppression of squamous cell carcinoma: case report and literature review. J Dermatolog Treat. 2003; 14 Suppl 2:3-6.
      View in: PubMed
    191. Maryles S, Rozenblit M, Lebwohl M. Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis. J Dermatolog Treat. 2003; 14 Suppl 2:7-16.
      View in: PubMed
    192. Spuls PI, Hadi S, Rivera L, Lebwohl M. Retrospective analysis of the treatment of psoriasis of the palms and soles. J Dermatolog Treat. 2003; 14 Suppl 2:21-5.
      View in: PubMed
    193. Lebwohl M, Menter A, Koo J, Feldman S. Case studies in severe psoriasis: A clinical strategy. J Dermatolog Treat. 2003; 14 Suppl 2:26-46.
      View in: PubMed
    194. Shyong EQ, Gorevic P, Lebwohl M, Phelps RG. Reactive angioendotheliomatosis and sarcoidosis. Int J Dermatol. 2002 Dec; 41(12):894-7.
      View in: PubMed
    195. Wei H, Zhang X, Wang Y, Lebwohl M. Inhibition of ultraviolet light-induced oxidative events in the skin and internal organs of hairless mice by isoflavone genistein. Cancer Lett. 2002 Nov 8; 185(1):21-9.
      View in: PubMed
    196. Tan MH, Meador SL, Singer G, Lebwohl MG. An open-label study of the safety and efficacy of limited application of fluticasone propionate ointment, 0.005%, in patients with atopic dermatitis of the face and intertriginous areas. Int J Dermatol. 2002 Nov; 41(11):804-9.
      View in: PubMed
    197. Gottlieb AB, Lebwohl M, Totoritis MC, Abdulghani AA, Shuey SR, Romano P, Chaudhari U, Allen RS, Lizambri RG. Clinical and histologic response to single-dose treatment of moderate to severe psoriasis with an anti-CD80 monoclonal antibody. J Am Acad Dermatol. 2002 Nov; 47(5):692-700.
      View in: PubMed
    198. Lebwohl M. Vitamin D and topical therapy. Cutis. 2002 Nov; 70(5 Suppl):5-8.
      View in: PubMed
    199. Persaud A, Lebwohl M. Imiquimod cream in the treatment of actinic keratoses. J Am Acad Dermatol. 2002 Oct; 47(4 Suppl):S236-9.
      View in: PubMed
    200. Persaud AN, Shamuelova E, Sherer D, Lou W, Singer G, Cervera C, Lamba S, Lebwohl MG. Clinical effect of imiquimod 5% cream in the treatment of actinic keratosis. J Am Acad Dermatol. 2002 Oct; 47(4):553-6.
      View in: PubMed
    201. Stern DK, Lebwohl M. Treatment of mycosis fungoides with oral bexarotene combined with PUVA. J Drugs Dermatol. 2002 Sep; 1(2):134-6.
      View in: PubMed
    202. Sherer DW, Lebwohl MG. 6-thioguanine in the treatment of psoriasis: a case report and literature review. J Cutan Med Surg. 2002 Nov-Dec; 6(6):546-50.
      View in: PubMed
    203. Lebwohl M. New developments in the treatment of psoriasis. Arch Dermatol. 2002 May; 138(5):686-8.
      View in: PubMed
    204. Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR. A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol. 2002 May; 41(5):269-74.
      View in: PubMed
    205. Endzweig-Gribetz CH, Brady C, Lynde C, Sibbald D, Lebwohl M. Drug interactions in psoriasis: the pros and cons of combining topical psoriasis therapies. J Cutan Med Surg. 2002 May-Jun; 6(3 Suppl):12-6.
      View in: PubMed
    206. Bershad S, Kranjac Singer G, Parente JE, Tan MH, Sherer DW, Persaud AN, Lebwohl M. Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel. Arch Dermatol. 2002 Apr; 138(4):481-9.
      View in: PubMed
    207. Ellis CN, Drake LA, Prendergast MM, Abramovits W, Boguniewicz M, Daniel CR, Lebwohl M, Stevens SR, Whitaker-Worth DL, Cheng JW, Tong KB. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol. 2002 Mar; 46(3):361-70.
      View in: PubMed
    208. Shyong EQ, Lu Y, Lazinsky A, Saladi RN, Phelps RG, Austin LM, Lebwohl M, Wei H. Effects of the isoflavone 4',5,7-trihydroxyisoflavone (genistein) on psoralen plus ultraviolet A radiation (PUVA)-induced photodamage. Carcinogenesis. 2002 Feb; 23(2):317-21.
      View in: PubMed
    209. Lebwohl M. Should we switch from combination UVA/UVB phototherapy units to narrowband UVB? Photodermatol Photoimmunol Photomed. 2002 Feb; 18(1):44-6; discussion 47-9.
      View in: PubMed
    210. Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol. 2001 Nov; 45(5):649-61; quiz 662-4.
      View in: PubMed
    211. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol. 2001 Oct; 45(4):487-98; quiz 499-502.
      View in: PubMed
    212. Lebwohl M, Drake L, Menter A, Koo J, Gottlieb AB, Zanolli M, Young M, McClelland P. Consensus conference: acitretin in combination with UVB or PUVA in the treatment of psoriasis. J Am Acad Dermatol. 2001 Oct; 45(4):544-53.
      View in: PubMed
    213. Tan MH, Lebwohl M, Esser AC, Wei H. The penetration of 0.005% fluticasone propionate ointment in eyelid skin. J Am Acad Dermatol. 2001 Sep; 45(3):392-6.
      View in: PubMed
    214. Stein RH, Lebwohl M. Acne therapy: clinical pearls. Semin Cutan Med Surg. 2001 Sep; 20(3):184-9.
      View in: PubMed
    215. Galadari I, Rigel E, Lebwohl M. The cost of psoriasis treatment. J Eur Acad Dermatol Venereol. 2001 Jul; 15(4):290-1.
      View in: PubMed
    216. Tan MH, Gordon M, Lebwohl O, George J, Lebwohl MG. Improvement of Pyoderma gangrenosum and psoriasis associated with Crohn disease with anti-tumor necrosis factor alpha monoclonal antibody. Arch Dermatol. 2001 Jul; 137(7):930-3.
      View in: PubMed
    217. Blum RR, Rahimizadeh A, Kardon N, Lebwohl M, Wei H. Genital lentigines in a 6-year-old boy with a family history of Cowden's disease: clinical and genetic evidence of the linkage between Bannayan-Riley-Ruvacalba syndrome and Cowden's disease. J Cutan Med Surg. 2001 May-Jun; 5(3):228-30.
      View in: PubMed
    218. Kuroda K, Sapadin A, Shoji T, Fleischmajer R, Lebwohl M. Altered expression of angiopoietins and Tie2 endothelium receptor in psoriasis. J Invest Dermatol. 2001 May; 116(5):713-20.
      View in: PubMed
    219. Lebwohl MG, Daniel CR, Leyden J, Mormon M, Shavin JS, Tschen E, Weiss J, Zone J. Efficacy and safety of terbinafine for nondermatophyte and mixed nondermatophyte and dermatophyte toenail onychomycosis. Int J Dermatol. 2001 May; 40(5):358-60.
      View in: PubMed
    220. Lamba S, Lebwohl M. Combination therapy with vitamin D analogues. Br J Dermatol. 2001 Apr; 144 Suppl 58:27-32.
      View in: PubMed
    221. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol. 2001 Mar; 137(3):280-4.
      View in: PubMed
    222. Sherer DW, Bercovitch L, Lebwohl M. Pseudoxanthoma elasticum: significance of limited phenotypic expression in parents of affected offspring. J Am Acad Dermatol. 2001 Mar; 44(3):534-7.
      View in: PubMed
    223. Lebwohl M, Elewski B, Eisen D, Savin RC. Efficacy and safety of terbinafine 1% solution in the treatment of interdigital tinea pedis and tinea corporis or tinea cruris. Cutis. 2001 Mar; 67(3):261-6.
      View in: PubMed
    224. Lebwohl M, Lombardi K, Tan MH. Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments. Int J Dermatol. 2001 Jan; 40(1):64-6.
      View in: PubMed
    225. Lebwohl M, Feldman SR, Walther R, Shelk J, Morgan P, Gutkin SW. Clinical management of psoriasis: principles and practice. Cutis. 2001 Jan; 67(1 Suppl):1-15.
      View in: PubMed
    226. Lebwohl MG, Tan MH, Meador SL, Singer G. Limited application of fluticasone propionate ointment, 0.005% in patients with psoriasis of the face and intertriginous areas. J Am Acad Dermatol. 2001 Jan; 44(1):77-82.
      View in: PubMed
    227. Fleischmajer R, Kuroda K, Hazan R, Gordon RE, Lebwohl MG, Sapadin AN, Unda F, Iehara N, Yamada Y. Basement membrane alterations in psoriasis are accompanied by epidermal overexpression of MMP-2 and its inhibitor TIMP-2. J Invest Dermatol. 2000 Nov; 115(5):771-7.
      View in: PubMed
    228. Gottlieb AB, Lebwohl M, Shirin S, Sherr A, Gilleaudeau P, Singer G, Solodkina G, Grossman R, Gisoldi E, Phillips S, Neisler HM, Krueger JG. Anti-CD4 monoclonal antibody treatment of moderate to severe psoriasis vulgaris: results of a pilot, multicenter, multiple-dose, placebo-controlled study. J Am Acad Dermatol. 2000 Oct; 43(4):595-604.
      View in: PubMed
    229. Abrams JR, Kelley SL, Hayes E, Kikuchi T, Brown MJ, Kang S, Lebwohl MG, Guzzo CA, Jegasothy BV, Linsley PS, Krueger JG. Blockade of T lymphocyte costimulation with cytotoxic T lymphocyte-associated antigen 4-immunoglobulin (CTLA4Ig) reverses the cellular pathology of psoriatic plaques, including the activation of keratinocytes, dendritic cells, and endothelial cells. J Exp Med. 2000 Sep 4; 192(5):681-94.
      View in: PubMed
    230. Berkowitz EZ, Lebwohl M. Cutaneous manifestations of inflammatory bowel disease. J Eur Acad Dermatol Venereol. 2000 Sep; 14(5):349-50.
      View in: PubMed
    231. Lebwohl M. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid. J Am Acad Dermatol. 2000 Aug; 43(2 Pt 3):S43-6.
      View in: PubMed
    232. Krueger GG, Feldman SR, Camisa C, Duvic M, Elder JT, Gottlieb AB, Koo J, Krueger JG, Lebwohl M, Lowe N, Menter A, Morison WL, Prystowsky JH, Shupack JL, Taylor JR, Weinstein GD, Barton TL, Rolstad T, Day RM. Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis? J Am Acad Dermatol. 2000 Aug; 43(2 Pt 1):281-5.
      View in: PubMed
    233. Buka R, Wei H, Sapadin A, Mauch J, Lebwohl M, Rudikoff D. Pseudoxanthoma elasticum and calcinosis cutis. J Am Acad Dermatol. 2000 Aug; 43(2 Pt 1):312-5.
      View in: PubMed
    234. Hecker D, Worsley J, Yueh G, Lebwohl M. In vitro compatibility of tazarotene with other topical treatments of psoriasis. J Am Acad Dermatol. 2000 Jun; 42(6):1008-11.
      View in: PubMed
    235. Goldstein AE, Lebwohl M, Wei H. Comparison of urinary 8-hydroxy-2'-deoxyguanosine in patients treated with topical corticosteroids, UV-B, and psoralen UV-A therapies. Arch Dermatol. 2000 Jun; 136(6):808-10.
      View in: PubMed
    236. Ringpfeil F, Lebwohl MG, Christiano AM, Uitto J. Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter. Proc Natl Acad Sci U S A. 2000 May 23; 97(11):6001-6.
      View in: PubMed
    237. Lebwohl M, Bernhard JD. The case for micrographically controlled skin surgery. J Am Acad Dermatol. 2000 Apr; 42(4):696-7.
      View in: PubMed
    238. Lebwohl M. From the literature: intralesional 5-FU in the treatment of hypertrophic scars and keloids: clinical experience. J Am Acad Dermatol. 2000 Apr; 42(4):677.
      View in: PubMed
    239. Gottlieb A, Krueger JG, Bright R, Ling M, Lebwohl M, Kang S, Feldman S, Spellman M, Wittkowski K, Ochs HD, Jardieu P, Bauer R, White M, Dedrick R, Garovoy M. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol. 2000 Mar; 42(3):428-35.
      View in: PubMed
    240. Urbán Z, Peyrol S, Plauchu H, Zabot MT, Lebwohl M, Schilling K, Green M, Boyd CD, Csiszár K. Elastin gene deletions in Williams syndrome patients result in altered deposition of elastic fibers in skin and a subclinical dermal phenotype. Pediatr Dermatol. 2000 Jan-Feb; 17(1):12-20.
      View in: PubMed
    241. Smith KC, Lebwohl M. Topical antipsoriatics. Skin Therapy Lett. 2000; 5(2):1-2.
      View in: PubMed
    242. Lebwohl M. Advances in psoriasis therapy. Dermatol Clin. 2000 Jan; 18(1):13-9, vii.
      View in: PubMed
    243. Cai L, Struk B, Adams MD, Ji W, Haaf T, Kang HL, Dho SH, Xu X, Ringpfeil F, Nancarrow J, Zäch S, Schaen L, Stumm M, Niu T, Chung J, Lunze K, Verrecchia B, Goldsmith LA, Viljoen D, Figuera LE, Fuchs W, Lebwohl M, Uitto J, Richards R, Hohl D, Ramesar R. A 500-kb region on chromosome 16p13.1 contains the pseudoxanthoma elasticum locus: high-resolution mapping and genomic structure. J Mol Med (Berl). 2000; 78(1):36-46.
      View in: PubMed
    244. Hecker D, Worsley J, Yueh G, Kuroda K, Lebwohl M. Interactions between tazarotene and ultraviolet light. J Am Acad Dermatol. 1999 Dec; 41(6):927-30.
      View in: PubMed
    245. Le Saux O, Urban Z, Göring HH, Csiszar K, Pope FM, Richards A, Pasquali-Ronchetti I, Terry S, Bercovitch L, Lebwohl MG, Breuning M, van den Berg P, Kornet L, Doggett N, Ott J, de Jong PT, Bergen AA, Boyd CD. Pseudoxanthoma elasticum maps to an 820-kb region of the p13.1 region of chromosome 16. Genomics. 1999 Nov 15; 62(1):1-10.
      View in: PubMed
    246. Savin R, Eisen D, Fradin MS, Lebwohl M. Tinea versicolor treated with terbinafine 1% solution. Int J Dermatol. 1999 Nov; 38(11):863-5.
      View in: PubMed
    247. Rosenstein BS, Phelps RG, Weinstock MA, Bernstein JL, Gordon ML, Rudikoff D, Kantor I, Shelton R, Lebwohl MG. p53 mutations in basal cell carcinomas arising in routine users of sunscreens. Photochem Photobiol. 1999 Nov; 70(5):798-806.
      View in: PubMed
    248. Baral J, Lebwohl M. Extramammary Paget's disease. Mt Sinai J Med. 1999 Oct-Nov; 66(5-6):341.
      View in: PubMed
    249. Lebwohl M. Acitretin in combination with UVB or PUVA. J Am Acad Dermatol. 1999 Sep; 41(3 Pt 2):S22-4.
      View in: PubMed
    250. Hobbs J, Lebwohl M, Lim HW. Improving the safety profile of long-term PUVA therapy. J Am Acad Dermatol. 1999 Sep; 41(3 Pt 1):496-7.
      View in: PubMed
    251. Lefkovits AM, Gordon M, Lebwohl M. Erythema nodosum. Mt Sinai J Med. 1999 Sep; 66(4):290.
      View in: PubMed
    252. Salasche SJ, Lebwohl M. Clinical pearl: vitamin E (alpha-tocopherol), 800 IU daily, may reduce retinoid toxicity. J Am Acad Dermatol. 1999 Aug; 41(2 Pt 1):260.
      View in: PubMed
    253. Lebwohl M. A comparison of once-daily application of mometasone furoate 0.1% cream compared with twice-daily hydrocortisone valerate 0.2% cream in pediatric atopic dermatitis patients who failed to respond to hydrocortisone: mometasone furoate study group. Int J Dermatol. 1999 Aug; 38(8):604-6.
      View in: PubMed
    254. Liu Z, Lu Y, Lebwohl M, Wei H. PUVA (8-methoxy-psoralen plus ultraviolet A) induces the formation of 8-hydroxy-2'-deoxyguanosine and DNA fragmentation in calf thymus DNA and human epidermoid carcinoma cells. Free Radic Biol Med. 1999 Jul; 27(1-2):127-33.
      View in: PubMed
    255. Koo J, Lebwohl M. Duration of remission of psoriasis therapies. J Am Acad Dermatol. 1999 Jul; 41(1):51-9.
      View in: PubMed
    256. Lim HW, Anderson TF, Douglass M, Koo J, Lebwohl M, Morison W, Taylor C, Zanolli M. Cost-effectiveness of methotrexate and Goeckerman therapy: a flawed analysis. Arch Dermatol. 1999 Jun; 135(6):717-8.
      View in: PubMed
    257. Wei H, Zhang X, Zhao JF, Wang ZY, Bickers D, Lebwohl M. Scavenging of hydrogen peroxide and inhibition of ultraviolet light-induced oxidative DNA damage by aqueous extracts from green and black teas. Free Radic Biol Med. 1999 Jun; 26(11-12):1427-35.
      View in: PubMed
    258. Leyden J, Dunlap F, Miller B, Winters P, Lebwohl M, Hecker D, Kraus S, Baldwin H, Shalita A, Draelos Z, Markou M, Thiboutot D, Rapaport M, Kang S, Kelly T, Pariser D, Webster G, Hordinsky M, Rietschel R, Katz HI, Terranella L, Best S, Round E, Waldstreicher J. Finasteride in the treatment of men with frontal male pattern hair loss. J Am Acad Dermatol. 1999 Jun; 40(6 Pt 1):930-7.
      View in: PubMed
    259. Abrams JR, Lebwohl MG, Guzzo CA, Jegasothy BV, Goldfarb MT, Goffe BS, Menter A, Lowe NJ, Krueger G, Brown MJ, Weiner RS, Birkhofer MJ, Warner GL, Berry KK, Linsley PS, Krueger JG, Ochs HD, Kelley SL, Kang S. CTLA4Ig-mediated blockade of T-cell costimulation in patients with psoriasis vulgaris. J Clin Invest. 1999 May; 103(9):1243-52.
      View in: PubMed
    260. Celebi JT, Tsou HC, Chen FF, Zhang H, Ping XL, Lebwohl MG, Kezis J, Peacocke M. Phenotypic findings of Cowden syndrome and Bannayan-Zonana syndrome in a family associated with a single germline mutation in PTEN. J Med Genet. 1999 May; 36(5):360-4.
      View in: PubMed
    261. Rudikoff D, Baral J, Lebwohl M. Psoriasis and Crohn's disease. Mt Sinai J Med. 1999 May; 66(3):206.
      View in: PubMed
    262. Sicari MC, Lebwohl M, Baral J, Wexler P, Gordon RE, Phelps RG. Photoinduced dermal pigmentation in patients taking tricyclic antidepressants: histology, electron microscopy, and energy dispersive spectroscopy. J Am Acad Dermatol. 1999 Feb; 40(2 Pt 2):290-3.
      View in: PubMed
    263. Lebwohl M, Gelfand JM, Tan MH. Clinically significant therapeutic interactions for the practicing dermatologist. Adv Dermatol. 1999; 14:1-26; discussion 27.
      View in: PubMed
    264. Sherer DW, Sapadin AN, Lebwohl MG. Pseudoxanthoma elasticum: an update. Dermatology. 1999; 199(1):3-7.
      View in: PubMed
    265. Lebwohl M. The role of salicylic acid in the treatment of psoriasis. Int J Dermatol. 1999 Jan; 38(1):16-24.
      View in: PubMed
    266. Lebwohl MG, Breneman DL, Goffe BS, Grossman JR, Ling MR, Milbauer J, Pincus SH, Sibbald RG, Swinyer LJ, Weinstein GD, Lew-Kaya DA, Lue JC, Gibson JR, Sefton J. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 1):590-6.
      View in: PubMed
    267. Lebwohl M, Poulin Y. Tazarotene in combination with topical corticosteroids. J Am Acad Dermatol. 1998 Oct; 39(4 Pt 2):S139-43.
      View in: PubMed
    268. Jorizzo JL, Lebwohl M, Tobey RE. The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea: a double-blind clinical trial. J Am Acad Dermatol. 1998 Sep; 39(3):502-4.
      View in: PubMed
    269. Lebwohl M, Yoles A, Lombardi K, Lou W. Calcipotriene ointment and halobetasol ointment in the long-term treatment of psoriasis: effects on the duration of improvement. J Am Acad Dermatol. 1998 Sep; 39(3):447-50.
      View in: PubMed
    270. Lebwohl M, Ellis C, Gottlieb A, Koo J, Krueger G, Linden K, Shupack J, Weinstein G. Cyclosporine consensus conference: with emphasis on the treatment of psoriasis. J Am Acad Dermatol. 1998 Sep; 39(3):464-75.
      View in: PubMed
    271. Wang Y, Rosenstein B, Goldwyn S, Zhang X, Lebwohl M, Wei H. Differential regulation of P53 and Bcl-2 expression by ultraviolet A and B. J Invest Dermatol. 1998 Sep; 111(3):380-4.
      View in: PubMed
    272. Gordon M, Lebwohl M. Generalized morphea. Mt Sinai J Med. 1998 Sep; 65(4):308.
      View in: PubMed
    273. Wei H, Bowen R, Zhang X, Lebwohl M. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis. 1998 Aug; 19(8):1509-14.
      View in: PubMed
    274. Sapadin AN, Lebwohl MG, Teich SA, Phelps RG, DiCostanzo D, Cohen SR. Periumbilical pseudoxanthoma elasticum associated with chronic renal failure and angioid streaks--apparent regression with hemodialysis. J Am Acad Dermatol. 1998 Aug; 39(2 Pt 2):338-44.
      View in: PubMed
    275. Gelfand JM, Rudikoff D, Lebwohl M, Klotman ME. Effect of UV-B phototherapy on plasma HIV type 1 RNA viral level: a self-controlled prospective study. Arch Dermatol. 1998 Aug; 134(8):940-5.
      View in: PubMed
    276. Liu Z, Lu Y, Rosenstein B, Lebwohl M, Wei H. Benzo[a]pyrene enhances the formation of 8-hydroxy-2'-deoxyguanosine by ultraviolet A radiation in calf thymus DNA and human epidermoid carcinoma cells. Biochemistry. 1998 Jul 14; 37(28):10307-12.
      View in: PubMed
    277. DeLauro TM, Lebwohl M. Dermatologic manifestations of systemic disease. Clin Podiatr Med Surg. 1998 Jul; 15(3):389-409, v.
      View in: PubMed
    278. Tan MH, Lebwohl M. Psoriasis. Drugs Today (Barc). 1998 Jul; 34(7):641-7.
      View in: PubMed
    279. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet. 1998 Jun 6; 351(9117):1715-21.
      View in: PubMed
    280. Wei H, Cai Q, Tian L, Lebwohl M. Tamoxifen reduces endogenous and UV light-induced oxidative damage to DNA, lipid and protein in vitro and in vivo. Carcinogenesis. 1998 Jun; 19(6):1013-8.
      View in: PubMed
    281. Patel B, Siskin S, Krazmien R, Lebwohl M. Compatibility of calcipotriene with other topical medications. J Am Acad Dermatol. 1998 Jun; 38(6 Pt 1):1010-1.
      View in: PubMed
    282. Ling MR, Swinyer LJ, Jarratt MT, Falo L, Monroe EW, Tharp M, Kalivas J, Weinstein GD, Asarch RG, Drake L, Martin AG, Leyden JJ, Cook J, Pariser DM, Pariser R, Thiers BH, Lebwohl MG, Babel D, Stewart DM, Eaglstein WH, Falanga V, Katz HI, Bergfeld WF, Hanifin JM, Young MR, et al. Once-weekly fluconazole (450 mg) for 4, 6, or 9 months of treatment for distal subungual onychomycosis of the toenail. J Am Acad Dermatol. 1998 Jun; 38(6 Pt 2):S95-102.
      View in: PubMed
    283. Nichols K, Desai N, Lebwohl MG. Effective sunscreen ingredients and cutaneous irritation in patients with rosacea. Cutis. 1998 Jun; 61(6):344-6.
      View in: PubMed
    284. Wei H, Ca Q, Rahn R, Zhang X, Wang Y, Lebwohl M. DNA structural integrity and base composition affect ultraviolet light-induced oxidative DNA damage. Biochemistry. 1998 May 5; 37(18):6485-90.
      View in: PubMed
    285. Uitto J, Boyd CD, Lebwohl MG, Moshell AN, Rosenbloom J, Terry S. International Centennial Meeting on Pseudoxanthoma Elasticum: progress in PXE research. J Invest Dermatol. 1998 May; 110(5):840-2.
      View in: PubMed
    286. Lebwohl M, Lebwohl O. Cutaneous manifestations of inflammatory bowel disease. Inflamm Bowel Dis. 1998 May; 4(2):142-8.
      View in: PubMed
    287. Lebwohl M, Ast E, Callen JP, Cullen SI, Hong SR, Kulp-Shorten CL, Lowe NJ, Phillips TJ, Rosen T, Wolf DI, Quell JM, Sefton J, Lue JC, Gibson JR, Chandraratna RA. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis. J Am Acad Dermatol. 1998 May; 38(5 Pt 1):705-11.
      View in: PubMed
    288. Morison WL, Baughman RD, Day RM, Forbes PD, Hoenigsmann H, Krueger GG, Lebwohl M, Lew R, Naldi L, Parrish JA, Piepkorn M, Stern RS, Weinstein GD, Whitmore SE. Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol. 1998 May; 134(5):595-8.
      View in: PubMed
    289. Wang Y, Zhang X, Lebwohl M, DeLeo V, Wei H. Inhibition of ultraviolet B (UVB)-induced c-fos and c-jun expression in vivo by a tyrosine kinase inhibitor genistein. Carcinogenesis. 1998 Apr; 19(4):649-54.
      View in: PubMed
    290. Hecker MS, Lebwohl MG. Recalcitrant pyoderma gangrenosum: treatment with thalidomide. J Am Acad Dermatol. 1998 Mar; 38(3):490-1.
      View in: PubMed
    291. Roenigk HH, Auerbach R, Maibach H, Weinstein G, Lebwohl M. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol. 1998 Mar; 38(3):478-85.
      View in: PubMed
    292. Lebwohl M, Kurtin S. Reactive perforating collagenosis. Mt Sinai J Med. 1998 Mar; 65(2):158.
      View in: PubMed
    293. Lebwohl M. Clinical efficacy and safety of tazarotene: optimizing clinical results. Cutis. 1998 Feb; 61(2 Suppl):27-9.
      View in: PubMed
    294. Lebwohl M. New horizons in the management of psoriasis: introduction. Cutis. 1998 Feb; 61(2 Suppl):7.
      View in: PubMed
    295. Lebwohl M, Tan MH. Psoriasis and stress. Lancet. 1998 Jan 10; 351(9096):82.
      View in: PubMed
    296. Lucky AW, Henderson TA, Olson WH, Robisch DM, Lebwohl M, Swinyer LJ. Effectiveness of norgestimate and ethinyl estradiol in treating moderate acne vulgaris. J Am Acad Dermatol. 1997 Nov; 37(5 Pt 1):746-54.
      View in: PubMed
    297. Lebwohl M, Kurtin S. Lyme disease. Mt Sinai J Med. 1997 Nov; 64(6):418.
      View in: PubMed
    298. Lebwohl M. Topical application of calcipotriene and corticosteroids: combination regimens. J Am Acad Dermatol. 1997 Sep; 37(3 Pt 2):S55-8.
      View in: PubMed
    299. Jorizzo JL, Magee K, Stewart DM, Lebwohl MG, Rajagopalan R, Brown JJ. Clobetasol propionate emollient 0.05 percent: hypothalamic-pituitary-adrenal-axis safety and four-week clinical efficacy results in plaque-type psoriasis. Cutis. 1997 Jul; 60(1):55-60.
      View in: PubMed
    300. Lebwohl M, Hecker D, Martinez J, Sapadin A, Patel B. Interactions between calcipotriene and ultraviolet light. J Am Acad Dermatol. 1997 Jul; 37(1):93-5.
      View in: PubMed
    301. Sadeh JS, Rudikoff D, Gordon ML, Bowden J, Goldman BD, Lebwohl M. Pustular and erythrodermic psoriasis complicated by acute respiratory distress syndrome. Arch Dermatol. 1997 Jun; 133(6):747-50.
      View in: PubMed
    302. Hecker D, Lebwohl M. Topical calcipotriene in combination with UVB phototherapy for psoriasis. Int J Dermatol. 1997 Apr; 36(4):302-3.
      View in: PubMed
    303. Freedman AM, Phelps RG, Lebwohl M. Pyoderma gangrenosum associated with anticardiolipin antibodies in a pregnant patient. Int J Dermatol. 1997 Mar; 36(3):205-7.
      View in: PubMed
    304. Lebwohl M. New treatments for alopecia areata. Lancet. 1997 Jan 25; 349(9047):222-3.
      View in: PubMed
    305. Zhang X, Rosenstein BS, Wang Y, Lebwohl M, Wei H. Identification of possible reactive oxygen species involved in ultraviolet radiation-induced oxidative DNA damage. Free Radic Biol Med. 1997; 23(7):980-5.
      View in: PubMed
    306. Zhang X, Rosenstein BS, Wang Y, Lebwohl M, Mitchell DM, Wei H. Induction of 8-oxo-7,8-dihydro-2'-deoxyguanosine by ultraviolet radiation in calf thymus DNA and HeLa cells. Photochem Photobiol. 1997 Jan; 65(1):119-24.
      View in: PubMed
    307. Pariser DM, Pariser RJ, Breneman D, Lebwohl M, Kalb R, Moore J, Moss H, Parker C, Fiedler V. Calcipotriene ointment applied once a day for psoriasis: a double-blind, multicenter, placebo-controlled study. Arch Dermatol. 1996 Dec; 132(12):1527.
      View in: PubMed
    308. Yoles A, Phelps R, Lebwohl M. Pseudoxanthoma elasticum and pregnancy. Cutis. 1996 Aug; 58(2):161-4.
      View in: PubMed
    309. Lebwohl M, Siskin SB, Epinette W, Breneman D, Funicella T, Kalb R, Moore J. A multicenter trial of calcipotriene ointment and halobetasol ointment compared with either agent alone for the treatment of psoriasis. J Am Acad Dermatol. 1996 Aug; 35(2 Pt 1):268-9.
      View in: PubMed
    310. Green MS, Prystowsky JH, Cohen SR, Cohen JI, Lebwohl MG. Infectious complications of erythrodermic psoriasis. J Am Acad Dermatol. 1996 May; 34(5 Pt 2):911-4.
      View in: PubMed
    311. Truter S, Rosenbaum-Fiedler J, Sapadin A, Lebwohl M. Calcification of elastic fibers in pseudoxanthoma elasticum. Mt Sinai J Med. 1996 May-Sep; 63(3-4):210-5.
      View in: PubMed
    312. Lebwohl M. Efficacy and safety of fluticasone propionate ointment, 0.005%, in the treatment of eczema. Cutis. 1996 Feb; 57(2 Suppl):62-8.
      View in: PubMed
    313. Menter MA, See JA, Amend WJ, Ellis CN, Krueger GG, Lebwohl M, Morison WL, Prystowsky JH, Roenigk HH, Shupack JL, Silverman AK, Weinstein GD, Yocum DE, Zanolli MD. Proceedings of the Psoriasis Combination and Rotation Therapy Conference. Deer Valley, Utah, Oct. 7-9, 1994. J Am Acad Dermatol. 1996 Feb; 34(2 Pt 1):315-21.
      View in: PubMed
    314. Ronna T, Lebwohl M. Cimetidine therapy for plantar warts. J Am Podiatr Med Assoc. 1995 Nov; 85(11):717-8.
      View in: PubMed
    315. Smalls G, Alaie M, Anzilotti M, Lebwohl M. Henoch-Schönlein purpura. Case report and review of the literature. J Am Podiatr Med Assoc. 1995 Nov; 85(11):710-2.
      View in: PubMed
    316. Lebwohl MG. The evolution of vitamin D analogues for the treatment of psoriasis. Arch Dermatol. 1995 Nov; 131(11):1323-4.
      View in: PubMed
    317. Lebwohl M, Baral J. Tar melanosis. Mt Sinai J Med. 1995 Oct; 62(5):412.
      View in: PubMed
    318. Lebwohl M, Abel E, Zanolli M, Koo J, Drake L. Topical therapy for psoriasis. Int J Dermatol. 1995 Oct; 34(10):673-84.
      View in: PubMed
    319. Lebwohl M. Future psoriasis therapy. Dermatol Clin. 1995 Oct; 13(4):915-23.
      View in: PubMed
    320. Schwartz E, Feinberg E, Lebwohl M, Mariani TJ, Boyd CD. Ultraviolet radiation increases tropoelastin accumulation by a post-transcriptional mechanism in dermal fibroblasts. J Invest Dermatol. 1995 Jul; 105(1):65-9.
      View in: PubMed
    321. Lebwohl M, Longas MO, Konstadt J, Koreen R, Grabowski GA, Phelps R, Lemlich G, Schwartz E. Hyaluronic acid and dermatan sulfate in non-lesional pseudoxanthoma elasticum skin. Clin Chim Acta. 1995 Jun 30; 238(1):101-7.
      View in: PubMed
    322. Lambroza E, Cohen SR, Phelps R, Lebwohl M, Braverman IM, DiCostanzo D. Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol. 1995 Jun; 32(6):987-93.
      View in: PubMed
    323. Gerardi CM, Kahn H, Lebwohl M. Case 2-1995. From the weekly grand rounds of the Department of Dermatology at the Mount Sinai Hospital. Mt Sinai J Med. 1995 May; 62(3):243-8.
      View in: PubMed
    324. Lebwohl M, Martinez J, Weber P, DeLuca R. Effects of topical preparations on the erythemogenicity of UVB: implications for psoriasis phototherapy. J Am Acad Dermatol. 1995 Mar; 32(3):469-71.
      View in: PubMed
    325. Khorenian SD, Lebwohl M. New cutaneous manifestations of systemic diseases. Am Fam Physician. 1995 Feb 15; 51(3):625-30.
      View in: PubMed
    326. Gerardi C, Lebwohl MG. Case 1-1994. From the Weekly Grand Rounds of the Department of Dermatology at the Mount Sinai Hospital. Mt Sinai J Med. 1995 Jan; 62(1):60-1.
      View in: PubMed
    327. Lebwohl MG, Schwartz E, Jacobs L, Lebwohl M, Sakai L, Fleischmajer R. Abnormalities of fibrillin in acquired cutis laxa. J Am Acad Dermatol. 1994 Jun; 30(6):950-4.
      View in: PubMed
    328. Fryer EJ, Lebwohl M. Pemphigus vulgaris after initiation of psoralen and UVA therapy for psoriasis. J Am Acad Dermatol. 1994 Apr; 30(4):651-3.
      View in: PubMed
    329. Lebwohl M, Neldner K, Pope FM, De Paepe A, Christiano AM, Boyd CD, Uitto J, McKusick VA. Classification of pseudoxanthoma elasticum: report of a consensus conference. J Am Acad Dermatol. 1994 Jan; 30(1):103-7.
      View in: PubMed
    330. Schwartz E, Cruickshank FA, Christensen CC, Perlish JS, Lebwohl M. Collagen alterations in chronically sun-damaged human skin. Photochem Photobiol. 1993 Dec; 58(6):841-4.
      View in: PubMed
    331. Yen BC, Kahn H, Schiller AL, Klein MJ, Phelps RG, Lebwohl MG. Multiple hamartoma syndrome with osteosarcoma. Arch Pathol Lab Med. 1993 Dec; 117(12):1252-4.
      View in: PubMed
    332. Lebwohl M, Peets E, Chen V. Limited application of mometasone furoate on the face and intertriginous areas: analysis of safety and efficacy. Int J Dermatol. 1993 Nov; 32(11):830-1.
      View in: PubMed
    333. Lebwohl M. Images in clinical medicine. Pseudoxanthoma elasticum. N Engl J Med. 1993 Oct 21; 329(17):1240.
      View in: PubMed
    334. Lebwohl M, Halperin J, Phelps RG. Brief report: occult pseudoxanthoma elasticum in patients with premature cardiovascular disease. N Engl J Med. 1993 Oct 21; 329(17):1237-9.
      View in: PubMed
    335. Lemlich G, Green M, Phelps R, Lebwohl M, Don P, Gordon M. Cutaneous reactions to vitamin K1 injections. J Am Acad Dermatol. 1993 Feb; 28(2 Pt 2):345-7.
      View in: PubMed
    336. Lebwohl M, Schwartz E, Lemlich G, Lovelace O, Shaikh-Bahai F, Fleischmajer R. Abnormalities of connective tissue components in lesional and non-lesional tissue of patients with pseudoxanthoma elasticum. Arch Dermatol Res. 1993; 285(3):121-6.
      View in: PubMed
    337. Davis K, Bottone EJ, Lucas D, Lebwohl M. Sterility of refrigerated injectable collagen syringes after injection of patient. J Am Acad Dermatol. 1992 Dec; 27(6 Pt 1):959-61.
      View in: PubMed
    338. Christiano AM, Lebwohl MG, Boyd CD, Uitto J. Workshop on pseudoxanthoma elasticum: molecular biology and pathology of the elastic fibers. Jefferson Medical College, Philadelphia, Pennsylvania, June 10, 1992. J Invest Dermatol. 1992 Nov; 99(5):660-3.
      View in: PubMed
    339. Bruckner HW, Gorbaty M, Lipsztein R, Kranjac G, Lebwohl MG. Treatment of a large high-grade neurofibrosarcoma with concomitant vinblastine, doxorubicin, and radiotherapy. Mt Sinai J Med. 1992 Oct; 59(5):429-32.
      View in: PubMed
    340. Keltz M, Lebwohl M, Bishop S. Peristomal pyoderma gangrenosum. J Am Acad Dermatol. 1992 Aug; 27(2 Pt 2):360-4.
      View in: PubMed
    341. Lebwohl M. Differential diagnosis of pigmented lesions of the skin. Mt Sinai J Med. 1992 May; 59(3):194-7.
      View in: PubMed
    342. Lebwohl M, Sacks S, Conant M, Connor J, Douglas JM, Eron L, Marlowe S, Mendelson J, Chen V, Bradstreet P, et al. Recombinant alpha-2 interferon gel treatment of recurrent herpes genitalis. Antiviral Res. 1992 Mar; 17(3):235-43.
      View in: PubMed
    343. Schwartz E, Thieberg M, Cruickshank FA, Lebwohl M. Elastase digestion of normal and pseudoxanthoma elasticum lesional skin elastins. Exp Mol Pathol. 1991 Oct; 55(2):190-5.
      View in: PubMed
    344. Dunaif A, Green G, Phelps RG, Lebwohl M, Futterweit W, Lewy L. Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. J Clin Endocrinol Metab. 1991 Sep; 73(3):590-5.
      View in: PubMed
    345. Sollberg S, Muona P, Lebwohl M, Peltonen J, Uitto J. Presence of type I and VI collagen mRNAs in endothelial cells in cutaneous neurofibromas. Lab Invest. 1991 Aug; 65(2):237-42.
      View in: PubMed
    346. Olsen EA, Cram DL, Ellis CN, Hickman JG, Jacobson C, Jenkins EE, Lasser AE, Lebwohl M, Leibsohn E, Medansky RS, et al. A double-blind, vehicle-controlled study of clobetasol propionate 0.05% (Temovate) scalp application in the treatment of moderate to severe scalp psoriasis. J Am Acad Dermatol. 1991 Mar; 24(3):443-7.
      View in: PubMed
    347. Gordon ML, Lebwohl MG, Phelps RG, Cohen SR, Fleischmajer R. Eosinophilic fasciitis associated with tryptophan ingestion. A manifestation of eosinophilia-myalgia syndrome. Arch Dermatol. 1991 Feb; 127(2):217-20.
      View in: PubMed
    348. Lebwohl M, Contard P. Interferon and condylomata acuminata. Int J Dermatol. 1990 Dec; 29(10):699-705.
      View in: PubMed
    349. Lebwohl M, Phelps R, Gordon M, Fleischmajer R. Diseases of the dermis. J Am Acad Dermatol. 1990 Aug; 23(2 Pt 1):295-9.
      View in: PubMed
    350. Schwartz E, Cruickshank FA, Lebwohl M. Determination of desmosines in elastin-related skin disorders by isocratic high-performance liquid chromatography. Exp Mol Pathol. 1990 Feb; 52(1):63-8.
      View in: PubMed
    351. London RD, Lebwohl M. Acquired ichthyosis and hyperparathyroidism. J Am Acad Dermatol. 1989 Oct; 21(4 Pt 1):801-2.
      View in: PubMed
    352. Fishman SJ, Phelps RG, Lebwohl M, Lieber C. Immunofluorescence and electron microscopic findings in a congenital arrector pili hamartoma. Am J Dermatopathol. 1989 Aug; 11(4):369-74.
      View in: PubMed
    353. Groisser D, Bottone EJ, Lebwohl M. Association of Pityrosporum orbiculare (Malassezia furfur) with seborrheic dermatitis in patients with acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol. 1989 May; 20(5 Pt 1):770-3.
      View in: PubMed
    354. Peltonen J, Jaakkola S, Lebwohl M, Renvall S, Risteli L, Virtanen I, Uitto J. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis. Lab Invest. 1988 Dec; 59(6):760-71.
      View in: PubMed
    355. Schwartz E, Cruickshank FA, Lebwohl MG. Elastase-like protease and elastolytic activities expressed in cultured dermal fibroblasts derived from lesional skin of patients with pseudoxanthoma elasticum, actinic elastosis, and cutis laxa. Clin Chim Acta. 1988 Aug 31; 176(2):219-24.
      View in: PubMed
    356. Freed JA, Pervez NK, Chen V, Lebwohl M, Damsker B. Cutaneous mycobacteriosis: occurrence and significance in two patients with the acquired immunodeficiency syndrome. Arch Dermatol. 1987 Dec; 123(12):1601-3.
      View in: PubMed
    357. Lebwohl M, Phelps RG, Yannuzzi L, Chang S, Schwartz I, Fuchs W. Diagnosis of pseudoxanthoma elasticum by scar biopsy in patients without characteristic skin lesions. N Engl J Med. 1987 Aug 6; 317(6):347-50.
      View in: PubMed
    358. Barax CN, Lebwohl M, Phelps RG. Multiple hamartoma syndrome. J Am Acad Dermatol. 1987 Aug; 17(2 Pt 2):342-6.
      View in: PubMed
    359. Norwood-Galloway A, Lebwohl M, Phelps RG, Raucher H. Subcutaneous fat necrosis of the newborn with hypercalcemia. J Am Acad Dermatol. 1987 Feb; 16(2 Pt 2):435-9.
      View in: PubMed
    360. Lemlich G, Schwam L, Lebwohl M. Kaposi's sarcoma and acquired immunodeficiency syndrome. Postmortem findings in twenty-four cases. J Am Acad Dermatol. 1987 Feb; 16(2 Pt 1):319-25.
      View in: PubMed
    361. Berman B, Davis-Reed L, Silverstein L, Jaliman D, France D, Lebwohl M. Treatment of verrucae vulgaris with alpha 2 interferon. J Infect Dis. 1986 Aug; 154(2):328-30.
      View in: PubMed
    362. Beitler M, Eng A, Kilgour M, Lebwohl M. Association between acrochordons and colonic polyps. J Am Acad Dermatol. 1986 Jun; 14(6):1042-4.
      View in: PubMed
    363. Rigel DS, Friedman RJ, Kopf AW, Weltman R, Prioleau PG, Safai B, Lebwohl MG, Eliezri Y, Torre DP, Binford RT, et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol. 1986 May; 14(5 Pt 1):857-60.
      View in: PubMed
    364. Longas MO, Wisch P, Lebwohl MG, Fleischmajer R. Glycosaminoglycans of skin and urine in pseudoxanthoma elasticum: evidence for chondroitin 6-sulfate alteration. Clin Chim Acta. 1986 Mar 28; 155(3):227-36.
      View in: PubMed
    365. Sonnenfeld KH, Bernd P, Sobue G, Lebwohl M, Rubenstein AE. Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells. Cancer Res. 1986 Mar; 46(3):1446-52.
      View in: PubMed
    366. Lebwohl M, Berman B, France DS. Addition of short-contact anthralin therapy to an ultraviolet B phototherapy regimen: assessment of efficacy. J Am Acad Dermatol. 1985 Nov; 13(5 Pt 1):780-4.
      View in: PubMed
    367. Fleischmajer R, Timpl R, Dziadek M, Lebwohl M. Basement membrane proteins, interstitial collagens, and fibronectin in neurofibroma. J Invest Dermatol. 1985 Jul; 85(1):54-9.
      View in: PubMed
    368. Lebwohl M, Fleischmajer R, Janowitz H, Present D, Prioleau PG. Metastatic Crohn's disease. J Am Acad Dermatol. 1984 Jan; 10(1):33-8.
      View in: PubMed
    369. Lebwohl MG, Distefano D, Prioleau PG, Uram M, Yannuzzi LA, Fleischmajer R. Pseudoxanthoma elasticum and mitral-valve prolapse. N Engl J Med. 1982 Jul 22; 307(4):228-31.
      View in: PubMed
    370. Poliak SC, Lebwohl MG, Parris A, Prioleau PG. Reactive perforating collagenosis associated with diabetes mellitus. N Engl J Med. 1982 Jan 14; 306(2):81-4.
      View in: PubMed
    Lebwohl's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067